No article text was recorded for this version.
blood-brain barrier bypass
Version 1 of 137 papers48 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Intranasal insulin for improving cognitive function in multiple sclerosis
- Blog: Ezetimibe attenuates functional impairment via inhibition of oxidative stress and inflammation in traumatic spinal cord injury
- Blog: Inhibition of AMD-Like Pathology With a Neurotrophic Compound in Aged Rats and 3xTg-AD Mice
- Blog: Mitochondrion-based organellar therapies for central nervous system diseases
- Blog: The Effect of Erythropoietin and Its Derivatives on Ischemic Stroke Therapy: A Comprehensive Review
- Blog: Research Progress of Tinnitus and Neuroinflammation
- Blog: Safety and biodistribution of exosomes derived from human induced pluripotent stem cells
- Blog: Quercetin carbon quantum dots: dual-target therapy for intracerebral hemorrhage in mice
- Blog: Intranasal administration of erythropoietin rescues the photoreceptors in degenerative retina: a noninvasive method to deliver drugs to the eye
- Blog: Spinal muscular atrophy with hypoplasia of the corpus callosum: a case report
- Blog: Early prediction of enteral nutrition feeding intolerance risk in neurocritical patients and development of a simplified risk scoring tables
- Blog: In Vivo Targeted Magnetic Resonance Imaging of Endogenous Neural Stem Cells in the Adult Rodent Brain
- Blog: A novel neuroprotective derived peptide of erythropoietin improved cognitive function in vascular dementia mice
- Blog: A synthetic BBB-permeable tripeptide GCF confers neuroprotection by increasing glycine in the ischemic brain
- Blog: Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19
- Blog: Enhanced BBB penetration and microglia-targeting nanomodulator for the two-pronged modulation of chronically activated microglia-mediated neuroinflammation in Alzheimer's disease
- Blog: Targeted Delivery of CNS‐Specific Hesperidin as a Leptin Sensitizer for Treating Obesity‐Associated Sleep‐Disordered Breathing
- Blog: Efficacy of dexamethasone combined with intravenous immunoglobulin for the treatment of pediatric autoimmune encephalitis
- Blog: Abstracts from the ASENT 2006 Annual Meeting March 8–11, 2006
- Blog: Design of Experiments (DoE)‐Optimized Polymeric Oxytocin Nanoparticles for Enhanced Nose‐to‐Brain Delivery
- Blog: Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia
- Blog: Cross-species efficacy of AAV-mediated ARSA replacement for metachromatic leukodystrophy
- Blog: Carbon quantum dots of ginsenoside Rb1 for application in a mouse model of intracerebral Hemorrhage
- Blog: A Comprehensive Study on Nanoparticle Drug Delivery to the Brain: Application of Machine Learning Techniques
- Blog: GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
- Blog: The unexpected PD-L1 suppression function of celery-derived extracellular vesicles improves lung cancer chemotherapy efficacy
- Blog: Stabilization of V1 interneuron-motor neuron connectivity ameliorates motor phenotype in a mouse model of ALS
- Blog: Impairments of GABAergic transmission in hippocampus mediate increased susceptibility of epilepsy in the early stage of Alzheimer’s disease
- Blog: Intranasal Delivery of Gene-Edited Microglial Exosomes Improves Neurological Outcomes after Intracerebral Hemorrhage by Regulating Neuroinflammation
- Blog: The synergistic effect of chlorotoxin-mApoE in boosting drug-loaded liposomes across the BBB
- Blog: Myelin endocytosis by brain endothelial cells causes endothelial iron overload and oligodendroglial iron hunger in hypoperfusion‐induced white matter injury
- Blog: Ferroptosis in neurodegenerative diseases: mechanisms and therapeutic potential of stem cell derivatives
- Blog: Human adipose-derived stem cells partially rescue the stroke syndromes by promoting spatial learning and memory in mouse middle cerebral artery occlusion model
- Blog: Ascorbic acid tethered polymeric nanoparticles enable efficient brain delivery of galantamine: An in vitro-in vivo study
- Blog: A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity
- Blog: Neurosurgical Approach for Spasticity
- Blog: Central Nervous System Biodistribution and Pharmacokinetics of Radiolabeled Tofersen in Rodents, Nonhuman Primates, and Humans
History & citation
Current · Permanent link
- Bypassing the Blood-Brain Barrier via Localized Administration merged into this direction (57% overlap)
- This direction split from blood-brain barrier permeability (blood-brain barrier penetration) (59% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_blood_brain_barrier_bypass_b68eb3c4,
title = {blood-brain barrier bypass},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/blood-brain-barrier-bypass/rdr_b68eb3c4a22b48efb976197fdcf7d713},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 1, frozen text):
@misc{lacuna_blood_brain_barrier_bypass_b68eb3c4_v1,
title = {blood-brain barrier bypass},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/blood-brain-barrier-bypass/rdr_b68eb3c4a22b48efb976197fdcf7d713/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}